Skip to content

BELVEMED

Active Private limited companyfounded 2023active for 3 yearsRue des Heids 15, 4630 SoumagneKBO/BCE: BE 0798.856.465

Lifetime

3 annual accounts with figures on one time axis
peak of €125,539 in 2024
€67,875▼ 45.9%
peak of €88,461 in 2024
€43,417▼ 50.9%
peak of €181,903 in 2025
€181,903▲ 31.4%
€36,213▼ 28.9%
Board2 names since 2023
2 directors and 1 other
Documentsfilings and deeds
06-05-202686 days before the deadline
2025micro format
Gross margin from €125,539 to €67,875Result from €88,461 to €43,417Equity from €138,486 to €181,903Debts from €50,909 to €36,213Cash from €59,829 to €79,859

Key points

from the 2025 annual accounts

Equity

€181,903 ▲ 31.4%

BELVEMED has made a profit in every financial year since 2023.

Turnover

≈ €150,000 estimated

The micro format states no turnover.

Liquidity

12.92 was 7.62 in 2024

Short-term debts fell from €18,417 to €14,188.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as BELVEMED has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for BELVEMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 27-02-2023
Director, since 27-02-2023
  • 50 sharesdeed of 01-03-2023
  • 50 sharesdeed of 01-03-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0798856465
Incorporation Founding capital of €3,000, 100 shares · Founded by (comparante) and (comparant) · (director) and (director) appointed · published on 01-03-2023 · Gazette deed
First establishment Rue des Heids 15, Soumagne
All 11 events

Comparable companies

same main activity, similar in size and age
Company
BELVEMED Soumagne €218,116 €67,875 83.4% -
Dr. Gertjan De Meyer Zedelgem €221,775 €63,007 34.2% -
MB Medical Services Brussels €247,978 €66,194 55.3% -
Dr. Janne Stroo Mol €210,141 €74,516 78.4% -
Dr. Anne Vandael Hasselt €248,370 €67,124 24.3% -
Dr. Sofie Buyse Zedelgem €248,184 €71,007 42.8% -
HAVALO Kinrooi €197,270 €65,727 67.6% -

These companies have the same main activity as BELVEMED: general medical practice (NACE 86210). They are comparable in size and age: total assets between €197,000 and €248,000, founded in 2023.

Official details

Source: KBO
Status
Active since 27-02-2023Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.342.492.4914630 Soumagne, since 27-02-2023
Financial year end
31 December
Peppol
Reachable since 05-12-2025
Company details

Annual accounts 2025

€218,116▲ 15.2%
Filing
Filed on 06-05-2026, 86 days before the end of the filing period
Financials

Insights on BELVEMED

BELVEMED files the micro format. That format states no turnover. The gross margin fell from €73,622 in 2023 to €67,875 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BELVEMED

What is the company number of BELVEMED?
The company number of BELVEMED is 0798.856.465. The VAT number is the same number with BE in front: BE 0798.856.465.
Where is BELVEMED based?
The registered office is at Rue des Heids 15, 4630 Soumagne.Company details
What does BELVEMED do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of BELVEMED?
BELVEMED is a private limited company (BV).
When was BELVEMED founded?
BELVEMED was founded on 27-02-2023.
Is BELVEMED still active?
Yes, BELVEMED is an active enterprise in the KBO register.
What is the turnover of BELVEMED?
The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €67,875 and 33 comparable companies (NACE 862). It probably lies between €110,000 and €190,000.Financials
Is BELVEMED profitable?
In financial year 2025, BELVEMED made a profit of €43,417.
Where can I find the annual accounts of BELVEMED?
BELVEMED filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BELVEMED due?
BELVEMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.